3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
2
Thoracic
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Leukemia, Myeloid, Acute
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Interventions
Filgrastim
4
Cyclophosphamide
4
Psychiatric Rehabilitation
3
Palliative Care
3
Busulfan
3
aflibercept
2
Vincristine
2
Thalidomide
2
Radiotherapy
2
Paclitaxel
2
Melphalan
2
Leucovorin
2
Irinotecan
2
Gemcitabine
2
Etoposide
2
Doxorubicin
2
Docetaxel
2
Celecoxib
2
Azacitidine
2
Analgesia
2
venetoclax
1
trimetrexate glucuronate
1
tazemetostat
1
tanespimycin
1
sargramostim
1
romidepsin
1
ripretinib
1
pembrolizumab
1
liposomal doxorubicin
1
ixabepilone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
Molecular Diagnostic Techniques
×
Other hematologic neoplasm
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled